A multi-center study has identified critical risk factors that increase the likelihood of death in children with a heart defect who are awaiting or have recently undergone heart transplantation, ...
Lupin has introduced Rivaroxaban for Oral Suspension in the US market, offering a generic version of Xarelto. This medication ...
It is also approved for thromboprophylaxis in children aged two years and above with congenital heart disease after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback